Haemonetics Prices Upsized Private Placement of $600 Million Convertible Senior Notes
/PRNewswire/ -- Haemonetics Corporation ("Haemonetics") (NYSE: HAE) today announced the pricing of its offering of $600,000,000 aggregate principal amount of 2....
Stay updated with breaking news from David Trenk. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Haemonetics Corporation ("Haemonetics") (NYSE: HAE) today announced the pricing of its offering of $600,000,000 aggregate principal amount of 2....
BOSTON, May 21, 2024 /PRNewswire/ -- Haemonetics Corporation today announced its intention to offer, subject to market and other conditions, $525,000,000 aggregate principal amount of Convertible...
/PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish fourth quarter and fiscal year 2024 financial results at 6:00...
BOSTON, April 4, 2024 /PRNewswire/ -- Haemonetics Corporation , a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, announced...
BOSTON, Feb. 21, 2024 /PRNewswire/ -- Haemonetics Corporation announced that Chris Simon, President and CEO, will participate in a fireside chat with investors at the Raymond James 45th Annual...